He, Chao-Bin <br/><br/>
Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.  [electronic resource] 

 -  PloS one  2017 
 - e0174769 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0174769  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviruses, Human--genetics<br/>Adult<br/>Aged<br/>Blood Platelets--immunology<br/>Carcinoma, Hepatocellular--immunology<br/>Chemoembolization, Therapeutic--methods<br/>Combined Modality Therapy<br/>Female<br/>Humans<br/>Inflammation--diagnosis<br/>Kaplan-Meier Estimate<br/>Leukocyte Count<br/>Liver Neoplasms--immunology<br/>Lymphocytes--immunology<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neutrophils--immunology<br/>Oncolytic Virotherapy--methods<br/>Oncolytic Viruses--genetics<br/>Platelet Count<br/>Prognosis<br/>Retrospective Studies<br/>Young Adult